Inhibition of vascular endothelial growth factor with a sequence-specific hypoxia response element antagonist
Open accessThe DOI matches its Crossref record; 47 of the 48 references it cites were found in a registry or an index.
Abstract
Vascular endothelial growth factor (VEGF) and its receptors have been implicated as key factors in tumor angiogenesis that are up-regulated by hypoxia. We evaluated the effects of DNA-binding small molecules on hypoxia-inducible transcription of VEGF . A synthetic pyrrole-imidazole polyamide designed to bind the hypoxia response element (HRE) was found to disrupt hypoxia-inducible factor (HIF) binding to HRE. In cultured HeLa cells, this resulted in a reduction of VEGF mRNA and secreted protein levels. The observed effects were polyamide-specific and dose-dependent. Analysis of genome-wide effects of the HRE-specific polyamide revealed that a number of hypoxia-inducible genes were down-regulated. Pathway-based regulation of hypoxia-inducible gene expression with DNA-binding small molecules may represent a new approach for targeting angiogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Interestingly, a synthetic pyrroleimidazole polyamide that inhibits in a sequence-specific fashion HIF binding to the HRE of the VEGF promoter (44) caused 264 and 73 genes to be down-regulated and up-regulated by 2-fold, respectively, at a concentration of 1 Amol/L.”
From Echinomycin, a small-molecule inhibitor of hypoxia-inducible factor-1 DNA-binding activity. (2005) · cites this paper as [44]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Vascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen
Leung, D. W., Cachianes, G., Kuang, W.-J., Goeddel, D. V., & Ferrara, N. (1989) · Science · doi:10.1126/science.2479986 · Cited by 4,986
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
Forsythe, J. A., Jiang, B.-H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D., & Semenza, G. L. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4604 · Cited by 3,981
Kim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S., & Ferrara, N. (1993) · Nature · doi:10.1038/362841a0 · Cited by 3,605
Plate, K. H., Breier, G., Weich, H. A., & Risau, W. (1992) · Nature · doi:10.1038/359845a0 · Cited by 2,275
Tischer, E., Mitchell, R., Hartman, T., Silva, M., Gospodarowicz, D., Fiddes, J. C., & Abraham, J. A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99049-6 · Cited by 1,476
Transcription factors as targets for cancer therapy
Darnell, J. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc906 · Cited by 1,194
Molecular basis of the VHL hereditary cancer syndrome
Kaelin, W. G. (2002) · Nature Reviews Cancer · doi:10.1038/nrc885 · Cited by 865
Self-citation
Research works printed but not linked: 5
- O'Rourke, J. F., Dachs, G. U., Gleadle, J. M., Maxwell, P. H., Pugh, C. W., Stratford, I. J., Wood, S. M. & Ratcliffe, P. J. (1997) Oncol. Res. 9, 327–332.9406238
- Grimshaw, M. J., Naylor, S. & Balkwill, F. R. (2002) Mol. Cancer Ther. 1, 1273–1281.12516960
- Kang, S. M., Maeda, K., Chung, Y. S., Onoda, N., Ogawa, Y., Takatsuka, S., Ogawa, M., Sawada, T., Nakata, B., Nishiguchi, Y., et al. (1997) Oncol. Rep. 4, 381–384.
- Lin, P. N., Sankar, S., Shan, S. Q., Dewhirst, M. W., Polverini, P. J., Quinn, T. Q. & Peters, K. G. (1998) Cell Growth Differ. 9, 49–58.9438388
- Reich, S., Fosnot, J., Kuroki, A., Tang, W. X., Yang, X. Y., Maguire, A., Bennett, J. & Tolentino, M. (2003) Mol. Vis. 9, 210–216.12789138
Cited by
Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway.
Kaelin, W. G., & Ratcliffe, P. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.04.009 · Cited by 3,251
Self-citationIntegration of Oxygen Signaling at the Consensus HRE
Wenger, R. H., Stiehl, D. P., & Camenisch, G. (2005) · Science's STKE · doi:10.1126/stke.3062005re12 · Cited by 1,032
Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer
Wigerup, C., Påhlman, S., & Bexell, D. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.04.009 · Cited by 687
“…HIF-1α/2α PAS-B domain Lee et al., 2009 PT2385 HIF-2α PAS-B domain Scheuermann et al., 2013 DNA binding Echinomycin HRE Kong et al., 2005 Polyamides HRE Olenyuk et al., 2004 Transcriptional activity Chetomin p300 recruitment Kung et al., 2004 Bortezomib p300 recruitment Kaluz et al., 2006, Shin…”
BackgroundMethodInfluentialEchinomycin, a small-molecule inhibitor of hypoxia-inducible factor-1 DNA-binding activity.
Kong, D., Park, E. J., Stephen, A. G., Calvani, M., Cardellina, J. H., Monks, A., Fisher, R. J., Shoemaker, R. H., & Melillo, G. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1235 · Cited by 508
“Interestingly, a synthetic pyrroleimidazole polyamide that inhibits in a sequence-specific fashion HIF binding to the HRE of the VEGF promoter (44) caused 264 Table 1.”
BackgroundAngiogenesis Inhibitors: Current Strategies and Future Prospects
Cook, K. M., & Figg, W. D. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20075 · Cited by 474
The VHL/HIF axis in clear cell renal carcinoma
Shen, C., & Kaelin, W. G. (2013) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.06.001 · Cited by 388
Self-citationEvaluation of HIF-1 inhibitors as anticancer agents
Semenza, G. L. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.08.006 · Cited by 363
Targeting Transcription Factors for Cancer Treatment
Lambert, M., Jambon, S., Depauw, S., & David-Cordonnier, M.-H. (2018) · Molecules · doi:10.3390/molecules23061479 · Cited by 352
Walsh, D. P., & Chang, Y.-T. (2006) · Chemical Reviews · doi:10.1021/cr0404141 · Cited by 296
Development of HIF‐1 inhibitors for cancer therapy
Onnis, B., Rapisarda, A., & Melillo, G. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00876.x · Cited by 268
Pathania, D., Millard, M., & Neamati, N. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.05.010 · Cited by 263
Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors
Xia, Y., Choi, H.-K., & Lee, K. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.01.033 · Cited by 278
Qiu, G.-Z., Jin, M.-Z., Dai, J.-X., Sun, W., Feng, J.-H., & Jin, W.-L. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.05.002 · Cited by 245
Targeting hypoxia cell signaling for cancer therapy
Melillo, G. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9059-x · Cited by 230
The von Hippel–Lindau protein, HIF hydroxylation, and oxygen sensing
Kaelin, W. G. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.165 · Cited by 214
Self-citationTargeting the hypoxia-inducible factor (HIF) pathway in cancer
Poon, E., Harris, A. L., & Ashcroft, M. (2009) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399409001173 · Cited by 213
Synthesis and Biological Properties of Sequence-Specific DNA-Alkylating Pyrrole−Imidazole Polyamides
Bando, T., & Sugiyama, H. (2006) · Accounts of Chemical Research · doi:10.1021/ar030287f · Cited by 202
The hypoxic microenvironment: A determinant of cancer stem cell evolution
Carnero, A., & Lleonart, M. (2016) · BioEssays · doi:10.1002/bies.201670911 · Cited by 199
Nickols, N. G., & Dervan, P. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704217104 · Cited by 189
Self-citationVasculogenic mimicry: Current status and future prospects
Zhang, S., Zhang, D., & Sun, B. (2007) · Cancer Letters · doi:10.1016/j.canlet.2006.12.036 · Cited by 183
Hypoxia Inducible Factor-1–Independent Pathways in Tumor Angiogenesis
Mizukami, Y., Kohgo, Y., & Chung, D. C. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0111 · Cited by 184
Zahnow, C. A. (2009) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399409001033 · Cited by 180
Sun, B., Zhang, D., Zhang, S., Zhang, W., Guo, H., & Zhao, X. (2007) · Cancer Letters · doi:10.1016/j.canlet.2006.08.016 · Cited by 170
“The downstream effectors of HIF-1a are associated with angiogenesis, cell proliferation, cell survival and glucose/iron metabolism, including EPO [35], VEGF, Fit-1[36], NOs [37], glucose transporters [38,39] and so on.”
BackgroundInhibiting Hypoxia-Inducible Factor 1 for Cancer Therapy
Melillo, G. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0235 · Cited by 166
“Perhaps not unexpectedly, only a few examples of HIF inhibitors that potentially target selective pathways associated with HIF activation have been described, among which echinomycin (29) and synthetic polyamides (30) that inhibit HIF-1 DNA binding, and chetomin (31), which blocks recruitment of coactivator p300/CBP (…”
BackgroundTargeting CREB for Cancer Therapy: Friend or Foe
Xiao, X., Li, B. X., Mitton, B., Ikeda, A., & Sakamoto, K. M. (2010) · Current Cancer Drug Targets · doi:10.2174/156800910791208535 · Cited by 160
“Another potential approach to target CREBCRE interaction is to employ the programmable N-methylpyrrole-N-methylimidazole polyamides [60], which can be designed to target specific DNA sequences and have been engineered to inhibit HIF-1α (hypoxia inducible factor 1α) and androgen receptor [61, 62].”
BackgroundAllosteric modulation of DNA by small molecules
Chenoweth, D. M., & Dervan, P. B. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906532106 · Cited by 153
Self-citationSelective Inhibition of Factor Inhibiting Hypoxia-Inducible Factor
McDonough, M. A., McNeill, L. A., Tilliet, M., Papamicaël, C. A., Chen, Q.-Y., Banerji, B., Hewitson, K. S., & Schofield, C. J. (2005) · Journal of the American Chemical Society · doi:10.1021/ja050841b · Cited by 147
Vadlapatla, R. K., Vadlapudi, A. D., & Mitra, A. K. (2013) · Current Drug Targets · doi:10.2174/13894501113149990015 · Cited by 157
“Pyrrole - imidazole polyamide [231]”
Sun, B., Zhang, D., Zhao, N., & Zhao, X. (2016) · Oncotarget · doi:10.18632/oncotarget.8461 · Cited by 143
“com/oncotarget binding to the hypoxia-response elements of target genes, such as vascular endothelial growth factor (VEGF), VEGF receptors, EMT inducers and stemness-associated genes [44-46].”
BackgroundModulating Hypoxia-Inducible Transcription by Disrupting the HIF-1–DNA Interface
Nickols, N. G., Jacobs, C. S., Farkas, M. E., & Dervan, P. B. (2007) · ACS Chemical Biology · doi:10.1021/cb700110z · Cited by 126
“Isolation of RNA and subsequent cDNA synthesis were as previously described (18).”
BackgroundMethodSelf-citationMakino, Y., Uenishi, R., Okamoto, K., Isoe, T., Hosono, O., Tanaka, H., Kanopka, A., Poellinger, L., Haneda, M., & Morimoto, C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700732200 · Cited by 120
Drugging the undruggable: Transcription therapy for cancer
Yan, C., & Higgins, P. J. (2013) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.11.002 · Cited by 120
Modulation of NF-κB-dependent gene transcription using programmable DNA minor groove binders
Raskatov, J. A., Meier, J. L., Puckett, J. W., Yang, F., Ramakrishnan, P., & Dervan, P. B. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1118506109 · Cited by 138
Self-citationHypoxia inducible factor-1: a novel target for cancer therapy
Belozerov, V. E., & Van Meir, E. G. (2005) · Anti-Cancer Drugs · doi:10.1097/01.cad.0000180116.85912.69 · Cited by 117
Inhibition of transcription factors with small organic molecules
Berg, T. (2008) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2008.07.023 · Cited by 137
In vivo modulation of hypoxia-inducible signaling by topographical helix mimetics
Lao, B. B., Grishagin, I., Mesallati, H., Brewer, T. F., Olenyuk, B. Z., & Arora, P. S. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1402393111 · Cited by 112
Self-citationRecent agents targeting HIF‐1α for cancer therapy
Hu, Y., Liu, J., & Huang, H. (2013) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24390 · Cited by 113
Shaik, F., Cuthbert, G. A., Homer‐Vanniasinkam, S., Muench, S. P., Ponnambalam, S., & Harrison, M. A. (2020) · Biomolecules · doi:10.3390/biom10121673 · Cited by 131
“The VEGFR1 promoter also contains a hypoxia-responsive element (HRE) sequence which enables HIF-1 binding to stimulate transcription of the VEGFR1 locus [43].”
BackgroundThe human oxygen sensing machinery and its manipulation
Chowdhury, R., Hardy, A., & Schofield, C. J. (2008) · Chemical Society Reviews · doi:10.1039/b701676j · Cited by 109
Repression of DNA-binding dependent glucocorticoid receptor-mediated gene expression
Muzikar, K. A., Nickols, N. G., & Dervan, P. B. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909192106 · Cited by 102
“Py-Im polyamides have previously been used to modulate gene expression in cell culture via inhibition of the transcription factor-DNA interface of both hypoxia inducible factor (20, 21) and androgen receptor (22) to their respective DNA response elements.”
MethodSelf-citationProtein domain mimetics as in vivo modulators of hypoxia-inducible factor signaling
Kushal, S., Lao, B. B., Henchey, L. K., Dubey, R., Mesallati, H., Traaseth, N. J., Olenyuk, B. Z., & Arora, P. S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1312473110 · Cited by 98
“HIF-1α forms a heterodimer with its β-subunit, aryl hydrocarbon receptor nuclear translocator (ARNT), to recognize hypoxia response element (HRE) and up-regulate expression of hypoxia-inducible genes, which are important contributors to tumor progression (11, 12, 15, 16).”
BackgroundSelf-citationSpecificity landscapes of DNA binding molecules elucidate biological function
Carlson, C. D., Warren, C. L., Hauschild, K. E., Ozers, M. S., Qadir, N., Bhimsaria, D., Lee, Y., Cerrina, F., & Ansari, A. Z. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914023107 · Cited by 108
“This class of molecules has been shown to regulate target genes in human cells and in mouse models of disease (13, 17, 18).”
BackgroundMethodImproved nuclear localization of DNA-binding polyamides
Nickols, N. G., Jacobs, C. S., Farkas, M. E., & Dervan, P. B. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl1042 · Cited by 96
“Fluorescein-labeled polyamides 1–3 were prepared as described previously (16).”
BackgroundMethodResultInfluentialSelf-citationStructural Basis for Cyclic Py-Im Polyamide Allosteric Inhibition of Nuclear Receptor Binding
Chenoweth, D. M., & Dervan, P. B. (2010) · Journal of the American Chemical Society · doi:10.1021/ja105068b · Cited by 97
Self-citationHypoxia, Hormones, and Endothelial Progenitor Cells in Hemangioma
Chang, E. I.-F., Chang, E. I.-Y., Thangarajah, H., Hamou, C. D., & Gurtner, G. C. (2007) · Lymphatic Research and Biology · doi:10.1089/lrb.2007.1014 · Cited by 91
“41,42 We have demonstrated that proliferating hemangiomas exhibit significant hypoxia, leading to HIF-1 (cid:2) upregulation/stabilization and subsequent expression of downstream targets.”
Hypoxia-dependent activation of HIF into a transcriptional regulator
Ruas, J. L., & Poellinger, L. (2005) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2005.04.001 · Cited by 102
Hypoxia-inducible factor-1α: A promising therapeutic target for vasculopathy in diabetic retinopathy
Li, H.-Y., Yuan, Y., Fu, Y.-H., Wang, Y., & Gao, X.-Y. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104924 · Cited by 88
A therapeutic role for targeting c-Myc/Hif-1- dependent signaling pathways
Podar, K., & Anderson, K. C. (2010) · Cell Cycle · doi:10.4161/cc.9.9.11358 · Cited by 88
Using Genome Sequence to Enable the Design of Medicines and Chemical Probes
Angelbello, A. J., Chen, J. L., Childs‐Disney, J. L., Zhang, P., Wang, Z.-F., & Disney, M. D. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00504 · Cited by 81
Block, K. M., Wang, H., Szabó, L. Z., Polaske, N. W., Henchey, L. K., Dubey, R., Kushal, S., László, C. F., Makhoul, J., Song, Z., et al. (2009) · Journal of the American Chemical Society · doi:10.1021/ja807601b · Cited by 79
Self-citationTargeting Protein–Protein Interactions in the HIF System
Wilkins, S. E., Abboud, M. I., Hancock, R. L., & Schofield, C. J. (2016) · ChemMedChem · doi:10.1002/cmdc.201600012 · Cited by 88
Cyclic Pyrrole−Imidazole Polyamides Targeted to the Androgen Response Element
Chenoweth, D. M., Harki, D. A., Phillips, J. W., Dose, C., & Dervan, P. B. (2009) · Journal of the American Chemical Society · doi:10.1021/ja901309z · Cited by 79
Self-citationProgramming Multiple Protein Patterns on a Single DNA Nanostructure
Cohen, J. D., Sadowski, J. P., & Dervan, P. B. (2007) · Journal of the American Chemical Society · doi:10.1021/ja0772400 · Cited by 77
Self-citationA Cell‐Permeable Synthetic Transcription Factor Mimic
Xiao, X., Yu, P., Lim, H., Sikder, D. S., & Kodadek, T. J. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200604485 · Cited by 77
Polyploid giant cancer cells and cancer progression
Zhou, X., Zhou, M., Zheng, M., Tian, S., Yang, X., Ning, Y., Li, Y., & Zhang, S. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1017588 · Cited by 86
“Hypoxia can activate invasion and metastasis-related genes, which make the cells more aggressive, and induce them to form VM (Olenyuk et al., 2004; Shams et al., 2004).”
BackgroundProgrammable DNA-binding small molecules
Blackledge, M. S., & Melander, C. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.04.023 · Cited by 75
Antiangiogenic Effect of Alkaloids
Alasvand, M., Assadollahi, V., Ambra, R., Hedayati, E., Kooti, W., & Peluso, I. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/9475908 · Cited by 78
“In hypoxic conditions, HIF-1 directly stimulates VEGF and its receptors, inducing angiogenesis [15, 16].”
BackgroundSequence-specific DNA binding Pyrrole–imidazole polyamides and their applications
Kawamoto, Y., Bando, T., & Sugiyama, H. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2018.01.026 · Cited by 71
Quantitative Microarray Profiling of DNA-Binding Molecules
Puckett, J. W., Muzikar, K. A., Tietjen, J. R., Warren, C. L., Ansari, A. Z., & Dervan, P. B. (2007) · Journal of the American Chemical Society · doi:10.1021/ja0744899 · Cited by 68
Self-citationHu, J., Valckenborgh, E. V., Menu, E., Bruyne, E. D., & Vanderkerken, K. (2012) · Disease Models & Mechanisms · doi:10.1242/dmm.008961 · Cited by 74
“, 2008), Polyamide 2 (Olenyuk et al., 2004), NSC 50352 (Park et al.”
Completion of a programmable DNA-binding small molecule library
Hsu, C. F., Phillips, J. W., Trauger, J. W., Farkas, M. E., Belitsky, J. M., Heckel, A., Olenyuk, B. Z., Puckett, J. W., Wang, C. C. C., & Dervan, P. B. (2007) · Tetrahedron · doi:10.1016/j.tet.2007.03.041 · Cited by 66
Self-citationHypoxia: syndicating triple negative breast cancer against various therapeutic regimens
Srivastava, N., Usmani, S. S., Subbarayan, R., Saini, R., & Pandey, P. K. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1199105 · Cited by 72
Li, Z., You, Q., & Zhang, X. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01596 · Cited by 65
DNA‐Binding Small Molecules as Inhibitors of Transcription Factors
Leung, C., Chan, D. S., Ma, V. P., & Ma, D. (2013) · Medicinal Research Reviews · doi:10.1002/med.21266 · Cited by 58
Ghosh, R., Samanta, P., Sarkar, R., Biswas, S., Saha, P., Hajra, S., & Bhowmik, A. (2022) · Molecules · doi:10.3390/molecules27165192 · Cited by 248
Dubey, R., Levin, M. D., Szabó, L., László, C., Kushal, S., Singh, J. B., Oh, P., Schnitzer, J. E., & Olenyuk, B. Z. (2013) · Journal of the American Chemical Society · doi:10.1021/ja400805b · Cited by 64
Self-citationNext Generation Hairpin Polyamides with ( R )-3,4-Diaminobutyric Acid Turn Unit
Dose, C., Farkas, M. E., Chenoweth, D. M., & Dervan, P. B. (2008) · Journal of the American Chemical Society · doi:10.1021/ja800888d · Cited by 57
Self-citationInhibition of Hypoxia-Inducible Factor-1α (HIF-1α) Protein Synthesis by DNA Damage Inducing Agents
Lou, J. J. W., Chua, Y. L., Chew, E. H., Gao, J., Bushell, M., & Hagen, T. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010522 · Cited by 57
“Indeed, a number of novel small molecule inhibitors of HIF have been identified through high-throughout screening of the National Cancer Institute (NCI) chemical repository or natural product-like combinatorial library [19–23].”
BackgroundChen, R., Liliental, J., Kowalski, P., Lu, Q., & Cohen, S. N. (2011) · Oncogene · doi:10.1038/onc.2010.623 · Cited by 60
“The effects of HSF4 in VEGF expression are mediated through HIF-1a The production of VEGF is controlled largely by transcription factors that include HIF-1, HIF-2 and SP1 (Jiang et al., 1997; Mazure et al., 1996, 1997; Tsuzuki et al., 2000; Bos et al., 2001; Semenza, 2003; Olenyuk et al., 2004; Pouyssegur et al., 2006…”
BackgroundZhang, L., Ding, P., Lv, H., Zhang, D., Liu, G., Yang, Z., Li, Y., Liu, J., & Zhang, S. (2014) · BioMed Research International · doi:10.1155/2014/903542 · Cited by 55
“Hypoxia can activate some invasion- and metastasis-associated tumor genes including erythropoietin [36], vascular endothelial growth factor (VEGF), and the VEGF receptor Fit-1 [37], enabling the cells to become more invasive and form VM structures in poor conditions.”
BackgroundTaniguchi, J., Pandian, G. N., Hidaka, T., Hashiya, K., Bando, T., Kim, K. K., & Sugiyama, H. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx693 · Cited by 56
Kamal, A., Kumar, P. P., Sreekanth, K., Seshadri, B. N., & Ramulu, P. Y. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.03.039 · Cited by 53
Programmable Oligomers for Minor Groove DNA Recognition
Doss, R. M., Marques, M. A., Foister, S., Chenoweth, D. M., & Dervan, P. B. (2006) · Journal of the American Chemical Society · doi:10.1021/ja0621795 · Cited by 52
Self-citationPeixoto, P., Liu, Y., Depauw, S., Hildebrand, M.-P., Boykin, D. W., Bailly, C., Wilson, W. D., & David-Cordonnier, M.-H. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn208 · Cited by 52
“Derived from distamycin, the pyrrole-imidazole polyamides series (5–9) were designed to specifically target some well-known transcription factors such as Ets, TBP, GCN-4 or NF-kB (5) and more recently the estrogen or androgen receptors (10), NF-Y (11), AP-1 (12) or HIF-1 (13,14).”
BackgroundMinoshima, M., Bando, T., Sasaki, S., Fujimoto, J., & Sugiyama, H. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn116 · Cited by 55
Sharifi, N., Hurt, E. M., Thomas, S. B., & Farrar, W. L. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0591 · Cited by 57
Scutellaria barbata inhibits angiogenesis through downregulation of HIF‐1 α in lung tumor
Shiau, A., Shen, Y., Hsieh, J., Wu, C., & Lee, C. (2012) · Environmental Toxicology · doi:10.1002/tox.21763 · Cited by 50
“Although hypoxic condition can induce the expression of VEGF, its promoter only has a single HRE that located at nucleotide positions 2947 to 2939 relative to the transcription start site (Olenyuk et al., 2004).”
BackgroundAnticancer activities of alkylating pyrrole–imidazole polyamides with specific sequence recognition
Shinohara, K., Bando, T., & Sugiyama, H. (2010) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e328334d8f9 · Cited by 52
Design and Synthesis of a Cell-Permeable Synthetic Transcription Factor Mimic
Xiao, X., Yu, P., Lim, H., Sikder, D. S., & Kodadek, T. J. (2007) · Journal of Combinatorial Chemistry · doi:10.1021/cc070023a · Cited by 51
Tzao, C., Lee, S.-C., Tung, H., Hsu, H., Hsu, W., Sun, G.-H., Yu, C., Jin, J., & Cheng, Y. (2008) · Disease Markers · doi:10.1155/2008/468323 · Cited by 59
“Continued efforts have been made in the development of HIF inhibitors, such as synthetic polyamides that inhibit HIF-1 DNA binding [28] and more recently identified small molecule inhibitors (e.”
BackgroundActivity of a Py–Im Polyamide Targeted to the Estrogen Response Element
Nickols, N. G., Szablowski, J. O., Hargrove, A. E., Li, B. C., Raskatov, J. A., & Dervan, P. B. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-1040 · Cited by 48
“In cell culture, selected polyamides have been used to modulate expression of genes induced by testosterone (11), TNF-alpha (12), hypoxia (13, 14), and dexamethasone (10).”
BackgroundSelf-citationMansouri, K., Mostafaei, A., Rezazadeh, D., Shahlaei, M., & Modarressi, M. H. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv461 · Cited by 48
HIF-1 mediated metabolic reprogramming in cancer: Mechanisms and therapeutic implications
Taneja, N., Chauhan, A., Kulshreshtha, R., & Singh, S. K. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122890 · Cited by 61
Therapeutic gene regulation using pyrrole–imidazole polyamides
Yu, Z., Pandian, G. N., Hidaka, T., & Sugiyama, H. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.02.001 · Cited by 49
Jayatunga, M. K. P., Thompson, S., McKee, T. C., Chan, M. C., Reece, K. M., Hardy, A., Sekirnik, R., Seden, P. T., Cook, K. M., McMahon, J. B., et al. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.06.006 · Cited by 49
Gene expression changes in a tumor xenograft by a pyrrole-imidazole polyamide
Raskatov, J. A., Nickols, N. G., Hargrove, A. E., Marinov, G. K., Wold, B. J., & Dervan, P. B. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1214267109 · Cited by 45
Self-citationIn vivo imaging of pyrrole-imidazole polyamides with positron emission tomography
Harki, D. A., Satyamurthy, N., Stout, D. B., Phelps, M. E., & Dervan, P. B. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806308105 · Cited by 44
“The binding of hypoxia-inducible factor (HIF-1 ) to the hypoxia response element (HRE) has been antagonized by polyamides, resulting in the decreased expression of HIF-1 -regulated genes, including VEGF (10, 11).”
BackgroundMethodInfluentialSelf-citationYang, Z., Yao, H., Fei, F., Li, Y., Qu, J., Li, C., & Zhang, S. (2018) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-018-2598-4 · Cited by 44
Isolation and characterization of coactivator-binding peptoids from a combinatorial library
Alluri, P. G., Liu, B., Yu, P., Xiao, X., & Kodadek, T. J. (2006) · Molecular BioSystems · doi:10.1039/b608924k · Cited by 46
Liu, G., Wang, Y., Fei, F., Wang, X., Li, C., Liu, K., Du, J., Cao, Y., & Zhang, S. (2018) · Melanoma Research · doi:10.1097/cmr.0000000000000491 · Cited by 41
Characterization and Solubilization of Pyrrole–Imidazole Polyamide Aggregates
Hargrove, A. E., Raskatov, J. A., Meier, J. L., Montgomery, D. C., & Dervan, P. B. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300380a · Cited by 43
Self-citationEnhancing the cellular uptake of Py–Im polyamides through next-generation aryl turns
Meier, J. L., Montgomery, D. C., & Dervan, P. B. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr970 · Cited by 42
“Compound 15 is a high-affinity binder of the 50-ATACGT-30 sequence found within the hypoxia response element (HRE) of the VEGF enhancer (6), while compounds 17–20 probe the ability of b-aryl turns to facilitate the uptake of polyamides with increased N-methylimidazole content, a known negative determinant of polyamide…”
BackgroundSelf-citationModifications at the C-Terminus To Improve Pyrrole−Imidazole Polyamide Activity in Cell Culture
Jacobs, C. S., & Dervan, P. B. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900256f · Cited by 41
“The biological activity against DFO-induced VEGF expression of HRE-targeted match (6-11) and mismatch (12-22) eight-ring hairpin polyamides was studied in U251 and LNCaP cell culture, and of ARE-targeted match (28-33) and mismatch (39-44) eight-ring hairpin polyamides against DHT-induced PSA expression in LNCaP cells.”
Self-citationSynthesis of Cyclic Py-Im Polyamide Libraries
Li, B. C., Montgomery, D. C., Puckett, J. W., & Dervan, P. B. (2012) · The Journal of Organic Chemistry · doi:10.1021/jo302053v · Cited by 41
Self-citationHypoxia‐Inducible Factor 1 Inhibitors
Melillo, G. (2007) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(07)35020-9 · Cited by 44
Foldamers in Medicinal Chemistry
Pasco, M., Dolain, C., & Guichard, G. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12565-x · Cited by 44
Small molecules targeting histone H4 as potential therapeutics for chronic myelogenous leukemia
Chou, C. J., Farkas, M. E., Tsai, S. M., Alvarez, D., Dervan, P. B., & Gottesfeld, J. M. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0130 · Cited by 37
Self-citationErwin, G. S., Bhimsaria, D., Eguchi, A., & Ansari, A. Z. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201405497 · Cited by 37
Modulating undruggable targets to overcome cancer therapy resistance
Passirani, C., Vessières, A., Regina, G. L., Link, W., & Silvestri, R. (2021) · Drug Resistance Updates · doi:10.1016/j.drup.2021.100788 · Cited by 41
Efficient synthesis and biological evaluation of proximicins A, B and C
Brucoli, F., Natoli, A., Marimuthu, P., Borrello, M. T., Stapleton, P. D., Gibbons, S., & Schätzlein, A. G. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.01.043 · Cited by 36
Metadata
- Authors
- Olenyuk, B. Z., Zhang, G.-J., Klco, J. M., Nickols, N. G., Kaelin, W. G., & Dervan, P. B.
- Affiliations
- California Institute of Technology (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2004-11-19
- Volume
- 101
- Issue
- 48
- Pages
- 16768-16773
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC534742
- OpenAlex
- W2000975094
- Cited by
- 219
- References
- 48
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 3 · 2023: 7 · 2022: 4 · 2021: 6 · 2020: 10 · 2019: 8 · 2018: 10 · 2017: 5 · 2016: 8 · 2015: 6 · 2014: 9 · 2013: 7 · 2012: 18
- FWCI
- 5.68
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- CaltechAUTHORS (California Institute of Technology) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Physical Sciences › Chemistry › Organic Chemistry › Heterocyclic Compound Synthesis and Bioactivity
- Keywords
- vascular endothelial growth factor, hypoxia response element, hypoxia-inducible factor, polyamide, tumor angiogenesis, hypoxia-inducible gene expression, VEGF mRNA, HeLa cells, gene expression profiling
- MeSH terms
- Hypoxia, Base Sequence, HeLa Cells, Humans, Promoter Regions, Genetic, RNA, Messenger, DNA Primers, Microscopy, Confocal, Reverse Transcriptase Polymerase Chain Reaction, Electrophoretic Mobility Shift Assay, Vascular Endothelial Growth Factor A
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.